Uncovered Weekly Wrap: Moderna, Etched, Cash Money

The short version

This Uncovered Weekly Wrap covers three stories: Moderna's Phase 3 success with a personalized melanoma vaccine built on AI, mRNA and genomic sequencing; Etched's $700 million raise at a $21 billion valuation for chips specialized in AI inference rather than competing head-on with Nvidia; and the 1998 Cash Money Records deal where Birdman and Slim kept ownership of their masters and gave up no equity, building a talent pipeline from Juvenile to Lil Wayne to Young Money to Drake and Nicki Minaj. The throughline across all three stories is that specialization and ownership, not scale for its own sake, create the biggest opportunities.

Moderna announced a successful Phase 3 trial for a personalized melanoma vaccine that sequences each tumor, uses AI to identify mutations, and manufactures a treatment specific to that patient.

The combination of AI, mRNA, and genomic sequencing is lowering the cost, time, and complexity barriers that previously blocked personalized medicine at scale.

Etched raised $700 million at a $21 billion valuation by focusing only on AI inference chips rather than trying to build an all-in-one competitor to Nvidia.

Inference is described as the repeated, high-volume execution of an already-trained AI model, distinct from training which is the process of building and refining the model.

In 1998, Birdman and Slim signed a deal with Universal for Cash Money Records that let them keep ownership of their masters and give up no equity.

Cash Money's growth came from a compounding talent pipeline starting with Juvenile, then Lil Wayne, who built Young Money, which brought in Drake and Nicki Minaj, with value flowing back to the label's ownership.

Moderna/Cancer Treatment

The Story:
Moderna announced a successful Phase 3 of a personalized melanoma cancer vaccine, and its stock skyrocketed. When most people hear the word “vaccine,” they think one formula for the masses. But this is different. Each tumor is sequenced, AI identifies the mutations, and Moderna manufactures a treatment built for that specific person.

The Real Story:
This is the AI promise we have been waiting for in healthcare. Not replacing doctors or creating a central control system for test results and health monitoring. This is personalized medicine delivered at scale. This could saves lives. The barrier has always been cost, time and complexity. Now, the stack of AI, mRNA, and genomic sequencing is creating a new way to think about cancer treatment.

The Shift:
Pharmaceutical companies have been really great at manufacturing one medication and giving it to millions. If the treatment continues to work across various cancer types, it opens the door for medicine built around an individual instead of the average.

Study Links:

A Clinical Study of Intismeran Autogenerated Plus Pembrolizumab in People With High-Risk Melanoma, from the National Library of Medicine
Merck and Moderna Press Announcement

Etched/AI Chips

The Story:
Etched raised $700 million with a $21 billion valuation. This is a bet that Nvidia’s chips might not be the most efficient for all the work. Etched decided to focus on one job and one job only—inference.

The Real Story:
This was a little bit of a sleeper story but it deserves more attention because of the opportunity. Most people take on a competitor by building something better to beat the competition. Now that AI workloads are becoming clearer and inference is exploding, the solution is creating the most tokens for the least money and power.

The Shift:
Etched isn’t going head-to-head with Nvidia, they are taking a small slice of the AI full-stack and doing it really well. Nvidia is a powerhouse because it’s the full-stack. But this move by Etched might signal that instead of building the all-in-one chip, companies will be looking to develop chips that are hyper-efficient at doing one particular job.

Inference 101

Think of inference as what happens after something is already trained. Training is the test kitchen, where you create and refine the recipe. Inference is the dinner rush when you make the recipe over and over again.

Ca$h Money Records/Birdman

The Story:
In 1998, Birdman and Slim struck a deal with Universal for Cash Money Records while keeping ownership of the masters and giving up no equity. This is one of the most important business stories in hip-hop.

The Real Story:
Cash Money took a different approach to building its label. It was a compounding talent machine. We start with Juvenile, then came Lil Wayne. Lil Wayne built Young Money. Young Money brought Drake and Nicki Minaj. Each star created leverage, audience, and new pipelines. Everything flows back to the top.

The Shift:
Oftentimes, fame is not the real business. Ownership is the business. Artists deliver the moment but ownership controls the rights, distribution and catalog. Birdman didn’t win big by being the biggest artist in the room. He became big by curating room all the artist sat in.

DREAM IN PUBLIC

One of the coolest things to watch is how people come together around a thing that’s not fully defined. As Uncovered continues to grow, we’ve been thinking about what it means to create a space that brings the most value to our VC’s, founders, operators, sponsors, and general enthusiasts that give their time and attention to us. We have an obsessive belief that Uncovered is the biggest champion of the people opting in. We are still determining what that looks like in practice, but feel like we are getting strong signals towards the right direction. Follow us on Insta: @glovejones.

THE FIND: Ordinal

We are a small team of Swiss Army knives. Social media is one function that consumes a fair amount of energy. In an ideal world, we would have a genius social media manager handling it all. But for now, we are building and organizing content across multiple channels. We have been leveraging Ordinal to curate, schedule and publish content across various social channels. It has caught mistakes when we’re moving too fast and gives us a visual of the week to come and where there might be some gaps. It’s been a key platform for Uncovered. Let us know what your social media stack looks like in the comments.

Every industry, every business model, there is a larger opportunity hiding inside of it. We’re here to help you find them. Follow Uncovered for more tech and AI news.

Questions this answers

What makes Moderna's new melanoma vaccine different from a traditional vaccine?

Instead of one formula given to the masses, each patient's tumor is sequenced, AI identifies the specific mutations, and Moderna manufactures a treatment built for that individual person.

What is Etched betting on with its $21 billion valuation?

Etched raised $700 million at a $21 billion valuation on the bet that Nvidia's chips aren't the most efficient for all AI work, so Etched is focusing solely on inference, the process of running an already-trained AI model repeatedly.

What is the difference between AI training and inference?

Training is compared to a test kitchen where you create and refine a recipe, while inference is the dinner rush where you make that recipe over and over again using an already-trained model.

How did Birdman and Slim structure the original Cash Money Records deal?

In 1998, Birdman and Slim struck a deal with Universal for Cash Money Records while keeping ownership of the masters and giving up no equity.

How did Cash Money Records grow from Juvenile to Drake?

Cash Money built a compounding talent machine starting with Juvenile, then Lil Wayne, who built Young Money, which brought in Drake and Nicki Minaj, with each star adding leverage and audience that flowed back to the label.